Found: 104
Select item for more details and to access through your institution.
Real-world data: come possono aiutare a migliorare la qualità dell'assistenza.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 134, doi. 10.33393/grhta.2021.2286
- By:
- Publication type:
- Article
Early Access in Oncology: Why Is It Needed?
- Published in:
- Global & Regional Health Technology Assessment, 2019, v. 2019, p. 1, doi. 10.1177/2284240319857072
- By:
- Publication type:
- Article
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 1, p. 72, doi. 10.3390/jpm12010072
- By:
- Publication type:
- Article
Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature Review.
- Published in:
- Case Reports in Oncological Medicine, 2018, p. 1, doi. 10.1155/2018/4714708
- By:
- Publication type:
- Article
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1601, doi. 10.3390/ijms21051601
- By:
- Publication type:
- Article
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1874, doi. 10.3390/ijms20081874
- By:
- Publication type:
- Article
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of smac/DIABLO from the mitochondria.
- Published in:
- Pathology & Oncology Research, 2006, v. 12, n. 3, p. 133, doi. 10.1007/BF02893359
- By:
- Publication type:
- Article
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221138657
- By:
- Publication type:
- Article
Preoperative Carboplatin-Paclitaxel-Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 9, p. 2881, doi. 10.1245/s10434-015-4371-0
- By:
- Publication type:
- Article
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 8, p. 2150, doi. 10.1245/s10434-011-1590-x
- By:
- Publication type:
- Article
Mesenchymal Progenitors Aging Highlights a mi R-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis.
- Published in:
- Stem Cells, 2015, v. 33, n. 3, p. 939, doi. 10.1002/stem.1897
- By:
- Publication type:
- Article
Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas.
- Published in:
- Stem Cells, 2015, v. 33, n. 3, p. 859, doi. 10.1002/stem.1903
- By:
- Publication type:
- Article
Examining technology-assisted rehabilitation for older adults' functional mobility: a network meta-analysis on efficacy and acceptability.
- Published in:
- NPJ Digital Medicine, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s41746-023-00907-7
- By:
- Publication type:
- Article
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00434-w
- By:
- Publication type:
- Article
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Evolution of HER2-low expression from primary to recurrent breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00343-4
- By:
- Publication type:
- Article
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00308-7
- By:
- Publication type:
- Article
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00223-x
- By:
- Publication type:
- Article
Use of Telemedicine to Improve Cognitive Functions and Psychological Well-Being in Patients with Breast Cancer: A Systematic Review of the Current Literature.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1353, doi. 10.3390/cancers15041353
- By:
- Publication type:
- Article
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1175, doi. 10.3390/cancers15041175
- By:
- Publication type:
- Article
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2262, doi. 10.3390/cancers13092262
- By:
- Publication type:
- Article
Health-Related Quality of Life in a Cohort of Breast Cancer Survivors over More Than 10 Years Post-Diagnosis and in Comparison to a Control Cohort.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1854, doi. 10.3390/cancers13081854
- By:
- Publication type:
- Article
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1458, doi. 10.3390/cancers13061458
- By:
- Publication type:
- Article
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 583, doi. 10.3390/cancers13030583
- By:
- Publication type:
- Article
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1303, doi. 10.3390/cancers12051303
- By:
- Publication type:
- Article
Immune characterization of breast cancer metastases: prognostic implications.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 127, doi. 10.1007/s10549-017-4518-8
- By:
- Publication type:
- Article
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 2, p. 295, doi. 10.1007/s10549-017-4191-y
- By:
- Publication type:
- Article
Whole exome sequencing of rare aggressive breast cancer histologies.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 1, p. 21, doi. 10.1007/s10549-016-3718-y
- By:
- Publication type:
- Article
A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 2, p. 295, doi. 10.1007/s10549-015-3675-x
- By:
- Publication type:
- Article
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 1, p. 117, doi. 10.1007/s10549-015-3655-1
- By:
- Publication type:
- Article
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 2, p. 411, doi. 10.1007/s10549-013-2552-8
- By:
- Publication type:
- Article
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 125, n. 3, p. 755, doi. 10.1007/s10549-010-1251-y
- By:
- Publication type:
- Article
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 1, p. 181, doi. 10.1007/s10549-010-0866-3
- By:
- Publication type:
- Article
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 115, n. 1, p. 131, doi. 10.1007/s10549-008-0048-8
- By:
- Publication type:
- Article
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 110, n. 1, p. 127, doi. 10.1007/s10549-007-9688-3
- By:
- Publication type:
- Article
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.625636
- By:
- Publication type:
- Article
Olaparib efficacy in patients with germline BRCA‐mutated, HER2‐negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 803, doi. 10.1002/ijc.34525
- By:
- Publication type:
- Article
Survival of metastatic breast carcinoma patients over a 20‐year period: A retrospective analysis based on individual patient data from six consecutive studies.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 8, p. 1742
- By:
- Publication type:
- Article
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 7, p. 1444, doi. 10.1002/cncr.10860
- By:
- Publication type:
- Article
PARP Inhibitors in Breast Cancer: Why, How, and When?
- Published in:
- 2018
- By:
- Publication type:
- Question & Answer
Potentiation by Tumor Necrosis Factor of Mitoxantrone Cytotoxicity to Human Ovarian Cancer Cell Lines.
- Published in:
- Cancer Science, 1992, v. 83, n. 7, p. 684, doi. 10.1111/j.1349-7006.1992.tb01966.x
- By:
- Publication type:
- Article
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 11, p. 1648, doi. 10.1007/s00259-015-3088-4
- By:
- Publication type:
- Article
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.
- Published in:
- Biomedicine Hub, 2020, v. 5, n. 3, p. 1, doi. 10.1159/000511209
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2692, doi. 10.1111/1759-7714.14531
- By:
- Publication type:
- Article
Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 1, p. 13, doi. 10.1111/1759-7714.13616
- By:
- Publication type:
- Article